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1. Introduction 
While protein functions such as binding or catalysis remain very difficult to predict 
computationally from primary sequences, approaches which involve the parallel processing 
of diverse proteins are remarkably powerful for the isolation of rare proteins with functions 
of interest.  
Stated using a Darwinian vocabulary, a repertoire of proteins can be submitted to 
selection according to a function of interest for isolation of the rare fittest proteins. Parallel 
processing strategies rely mainly on the design of in vitro selections of proteins. To ensure 
that complex molecular information can be extracted after selection from protein 
populations, several types of links between the genotype and the phenotype have been 
designed for the parallel processing of proteins: they include the display of nascent 
proteins on the surface of the ribosome bound to mRNA, the display of proteins as fusions 
with bacteriophage coat proteins and the fusion of proteins to membrane proteins 
expressed on the surface of yeast cells. In the first two display strategies, covalent and non 
covalent bonds define chemical links between the genotype and the protein, while in the 
last case compartmentation by a membrane provides the link between the protein and the 
corresponding gene. 
While parallel processing strategies allow the analysis of up to 1014 proteins, serial 
processing is convenient for the analysis of tens to thousands of proteins, with the 
exceptions of millions of proteins in the specific case where fluorescent sorting can be 
adapted experimentally.  
In this review, the power of parallel processing strategies for the identification of proteins of 
interest will be underlined. It is useful to combine them with serial processing approaches 
such as activity screening and the computational alignment of multiple sequences. These 
molecular information processing (MIP) strategies yield sequence-activity relationships for 
proteins, whether they are binders or catalysts (Figure 1). 
2. Parallel processing strategies 
Display technologies in vitro are based on the same « idea »: the creation of large diverse 
libraries of proteins followed by their interrogation using display technologies in vitro. An 
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antibody fragment (single-chain Fv (scFv), camelids single domain antibodies (VHH) or Fab 
fragments) (Figure 2) or an enzyme can be presented on phage or yeast surfaces as well as 
on ribosomes, while the encoding nucleotide sequence is incorporated within or is 
physically attached.  
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DIVERSITY FUNCTION
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Fig. 1. Parallel and experimental processing combined with serial and computational 
processing prior to thermodynamic and kinetic characterization allow protein engineering 
towards new functions. 
 
 
 
 
 
Fig. 2. Representation of mammalian antibodies and synthetic fragments: Fab, scFv and 
VHH. 
This link of phenotype to genotype enables selection and enrichment of molecules with high 
specific affinities or exquisite catalytic properties together with the co-selected gene (Figure 
3). Consequently, the need for serial screening is reduced to a minimum. 
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Fig. 3. Directed protein evolution cycles yield sequence-activity relationships for proteins. A 
cycle consists of the selection of proteins according to their function and of the amplification 
of their corresponding nucleic acids which are linked to the proteins. Iteration of the cycles 
diminishes the background of the selection and yields a selected population enriched in 
proteins with functions of interest. Characterization of these selected proteins and their 
genes establishes sequence-activity relationships. 
2.1 Phage display 
In 1985, M13 phage displaying a specific peptide antigen on its surface was isolated from a 
population of wild type phage, based on the affinity of a specific antibody for the peptide 
(Smith, 1985). Antibody variable domain were successfully displayed by McCafferty et al in 
1990, enabling the selection of antibodies themselves (McCafferty et al., 1990) (Figure 4).  
 
 
protein
p3
capsid
phagemid
protein fusionphage particle
 
Fig. 4. Bacteriophage particle highlighting the link between a protein fused to a phage coat 
protein and its corresponding gene located on the phagemid. In the case of Inovirus, the 
filamentous phage particle is a cylinder with a diameter of three to five nanometers, which 
is about one micrometer long. 
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Phage display technology (Figure 4) enables the selection from repertoires of antibody 
fragments (scFv, Fab, VHH) displayed on the surface of filamentous bacteriophage (Smith, 
1985). VHH domains are displayed by fusion to the viral coat protein, allowing phage with 
antigen binding activities (and encoding the antibody fragments) to be selected by panning 
on antigen. The selected phage can be grown after each round of panning and selected 
again, and rare phage (< 1/106) isolated over several rounds of panning.  
The antibody fragments genes population is first isolated from lymphocytes then converted 
to phage-display format using PCR. The PCR products are digested and ligated into phage 
vector. Subsequent transformation usually yield libraries of 106 to 1011 clones, each clone 
corresponding to a specific antibody fragments (VHH, scFv, Fab). This library is panned 
against the antigen then expression of selected clones is performed. Their biochemical 
characteristics are analyzed (purity, affinity, specificity) as well as their biological 
characteristics. 
The major advantages of phage display compared with other display technologies are its 
robustness, simplicity, and the stability of the phage particles, which enables selection on 
cell surfaces (Ahmadvand et al., 2009), tissue sections (Tordsson et al., 1997) and even in vivo 
(Pasqualini & Ruoslahti, 1996). However, because the coupling of genotype and phenotype 
(i.e. protein synthesis and assembly of phage particles) takes place in bacteria, the encoding 
DNA needs to be imported artificially. Library size is therefore restricted by transformation 
efficiency. Despite great improvements in this area, the largest reported libraries still 
comprise no more than 1010 to 1011 different members. Moreover, the amplification of 
selected variants in vivo can lead to considerable biases. Antibody fragments that are toxic 
for the host, poorly expressed or folded, inefficiently incorporated into the phage particle or 
susceptible to proteolysis or aggregation slow down the bacterial growth and display less 
efficiently. This reduces the library diversity and enables a low potency but fast growing 
clone to dominate a whole population after just a few rounds of selection. 
2.2 Ribosome display 
Ribosome display was first developed by Dower et al (Mattheakis et al., 1994) where mRNA, 
ribosome and correctly folded functional peptide in a linked assembly could be used for 
screening and selection (Figure 5).  
 
protein
mRNA ribosome
 
Fig. 5. Ribosome providing the link between the nascent protein and the corresponding 
mRNA. Such complexes are stabilized in the absence of stop codons and at low 
temperatures. 
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In ribosome display, a DNA library coding for particular proteins, for instance scFv or VHH 
fragments of antibodies, is transcribed in vitro. The mRNA is purified and used for in vitro 
translation. Because the mRNA lacks a stop codon, the ribosome stalls at the end of the 
mRNA, giving rise to a ternary complex of mRNA, ribosome and functional protein. A 
library of these ternary complexes is tested against the potential ligand (in the case of the 
antibodies, against the antigen). The binding of the ternary complexes (ribosome, mRNA 
and protein) to the ligand allows the recovery of the encoding mRNA that is linked to it and 
that can be transcribed into cDNA by reverse transcriptase-PCR (RT-PCR). Cycles of 
selection and recovery can be iterated both to enrich rare ligand-binding molecules, and to 
select molecules with the best affinity. 
Ribosome display has been used for the selection of proteins, such as scFv antibody 
fragments and alternative binding scaffolds with specificity and affinity to peptides (Hanes 
& Pluckthun, 1997), proteins (Hanes et al., 2000; Knappik et al., 2000; Binz et al., 2004; Lee et 
al., 2004; Mouratou et al., 2007) and nucleic acids (Schaffitzel et al., 2001). Using transition-
state analogs or enzyme inhibitors that bind reversibly to their enzyme (suicide substrates), 
ribosome display can also be used for the selection for enzymatic activity. 
As it is entirely performed in vitro, there are two main advantages over other selection 
strategies. First, the diversity is not limited by the transformation efficiency of bacterial cells, 
but only by the number of ribosomes and different mRNA molecules present in the test 
tube. According to the fact that the functional diversity is given by the number of ribosomal 
complexes that display a functional protein, this number is limited by the number of 
functional ribosomes or different mRNA molecules, whichever is smaller. An estimate 
representing a lower limit, of the number of active complexes with folded protein was 
determined as 2.6 x 1011 per milliter of reaction (Zahnd et al., 2007) and probably is about 
1013. Second, random mutations can be introduced easily after each selection rounds, as no 
library must be transformed after any diversification steps. This allows facile directed 
evolution of binding proteins over several generations.  
However, ribosome display suffers some drawbacks because RNA is extremely labile to 
ubiquitous Rnases, because the ternary RNA-ribosome-protein complex is very sensitive to 
heat denaturation and to salt concentration and because large proteins such as DNA 
polymerases cannot necessarily be produced by in vitro translation.  
2.3 Yeast surface display 
Yeast surface display (YSD) was first demonstrated as a method to immobilize enzymes and 
pathogen-derived proteins for vaccine development. The -galactosidase gene from 
Cyamopsis tetragonoloba was fused to the C terminal half of -agglutinin, a cell wall anchored 
mating protein in S. cerevisiae (Schreuder et al., 1993).  
Increased stability was seen for the enzyme when linked to the cell wall, compared with 
direct secretion of the full -galactosidase enzyme into the media. Early work also used the 
flocculin Flo1p as an anchor to attach -galactosidase to the cell wall, with similar results 
(Schreuder et al., 1996). Both -agglutinin and flocculin, along with cell wall proteins such as 
Cwp1p, Cwp2p, Tip1p, and others, belong to the glycosylphosphatidylinositol (GPI) family 
of cell wall proteins that can be used directly for display (Kondo & Ueda, 2004). These 
proteins are directed to the plasma membrane via GPI anchors and subsequently are linked 
directly to the cell wall through a -1,6-glucan bridge for incorporation into the 
mannoprotein layer (Kondo & Ueda, 2004). These large intact proteins as well as their C-
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terminal fragments have been demonstrated to mediate display of a range of heterologous 
proteins upon protein fusion.  
The -agglutinin system developped by Wittrup et al (Boder & Wittrup, 1997; Boder et al., 
2000; Boder & Wittrup, 2000) uses Aga2p as the display fusion partner. A disulfide linkage 
between Aga1p, a GPI/-1,6-glucan-anchored protein, and Aga2p anchors the protein to the 
cell wall. Thus, coexpression of Aga1p with an Aga2p fusion leads to cell wall-anchored 
protein on the surface of yeast via disulfide bonding. The majority of applications of YSD 
utilize now the Aga2p anchor system. 
In the yeast surface display system (Figure 6), the antibody fragment (scFv for example) is 
fused to the adhesion subunit of the yeast agglutinin protein Aga2p, which attaches to the 
yeast cell wall through disulfide bonds to Aga1p. Each yeast cell typically displays 1.104 to 
1.105 copies of the scFv, and variations in surface expression can be measured through 
immuno-fluorescence labeling of either the hemagglutinin or c-Myc epitope tag flanking the 
scFv. 
 
yeast cell
plasmid
protein fusion
 
Fig. 6. Yeast cell providing the link between a protein of interest fused to a membrane 
protein and its corresponding gene located on a plasmid. 
In the yeast surface display system (Figure 6), the antibody fragment (scFv for example) is 
fused to the adhesion subunit of the yeast agglutinin protein Aga2p, which attaches to the 
yeast cell wall through disulfide bonds to Aga1p. Each yeast cell typically displays 1.104 to 
1.105 copies of the scFv, and variations in surface expression can be measured through 
immuno-fluorescence labeling of either the hemagglutinin or c-Myc epitope tag flanking the 
scFv. Likewise, binding to a soluble antigen of interest can be determined by labeling of 
yeast with biotinylated antigen and a secondary reagent such as streptavidin conjugated to a 
fluorophore. The display of scFv antibody fragments on the surface of yeast is a powerful 
and robust technique for the selection of affinity reagents (van den Beucken et al., 2003). 
Using yeast display for probing immune libraries offers one major advantages over 
alternative systems. The main advantage is that the scFv displaying yeast can be isolated by 
FACS and characterized by flow cytometry. The use of FACS in the selection procedure 
allows the visualization of antigen binding in real-time and the enrichment of each step in 
the selection can be easily quantified using statistical analyses. Modern flow cytometers can 
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easily screen millions of binding events in only a few minutes, and the precision of sorting 
antigen-binding yeast while eliminating nonspecific interactions facilitates large 
enrichments in a relatively short period of time. In addition, following selection of scFv 
clones, YSD allows the determination of steady-state kinetic parameters by flow cytometry 
(KD value determination (VanAntwerp & Wittrup, 2000)).  
However, current yeast display technology is limited by the size of libraries that can be 
generated and, typically, only libraries of between 106 and 107 mutants are routinely 
possible using conventional in vitro cloning and transformation. 
3. Binders analyzed by parallel processing 
This chapter will focus on antibodies, the major class of known binding proteins. 
3.1 Introduction on the natural diversity of immunoglobulins 
One characteristic of the immune response in vertebrate is the possibility to raise 
immunoglobulin (Ig) against any type of antigen (Ag), known or unknown. An Ig contains 
two regions: the Variable domain involved in the binding with the Ag and the Constant 
domain with effector functions. Each Ig is unique and the variable domain, which is present 
in each heavy and light chain of every antibody, differ from one antibody to an other. 
Differences between the variable domains are located on three loops known as 
complementarity determining regions CDR1, CDR2 and CDR3. CDRs are supported within 
the variable domains by conserved framework regions. The variability of Ig is based on two 
phenomena: somatic recombination and somatic hypermutation (SHM).  
Somatic recombination of Ig, also known as V(D)J recombination, involves the generation of 
a unique Ig variable region. The variable region of each immunoglobulin heavy or light 
chain is encoded in several gene segments. These segments are called variable (V), diversity 
(D) and joining (J) segments. V, D and J segments are found in Ig heavy chains, but only V 
and J segments are found in Ig light chains. The IgH locus contains up to 65 VH genes, 27 D 
genes and 6 J genes while the IgL locus contains 40 V genes and 4-5 J genes, knowing that 
there are two light chains kappa and lambda. In the bone marrow, each developing B cell 
will assemble an immunoglobulin variable region by randomly selecting and combining one 
V, one D and one J gene segment (or one V and one J segment in the light chain). For heavy-
chains there are about 10530 potential recombinations (65x27x6) and for light chains 360 
potential recombinations (200+160). Moreover some mutations (referred as N-diversity 
somatic mutations) occur during recombination increasing the diversity by a factor 103. 
These two phenomena, recombination and somatic mutations, lead to about 106-107 
possibilities for heavy chains and 3.5 105 possibilities for light chains generating the 
formation of about 2.1012 different antibodies and thus different antigen specificities 
(Figure 7) (Jones & Gellert, 2004).  
Following activation with antigen, B cells begin to proliferate rapidly. In these rapidly 
dividing cells, the genes encoding the variable domains of the heavy and light chains 
undergo a high rate of point mutation, by a process called somatic hypermutation (SHM). 
The SHM mutation rate is about 10-3 per base pair and per cell division, that is 
approximately one million times above the replicative mutation rate. As a consequence, any 
daughter B cells will acquire slight amino acid differences in the variable domains of their 
antibody chains. 
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This serves to increase the diversity of the antibody pool and impacts the antibody’s 
antigen-binding affinity. Some point mutations will result in the production of antibodies 
that have a weaker interaction (low affinity) with their antigen than the original antibody, 
and some mutations will generate antibodies with a stronger interaction (high affinity). It 
has been estimated that the affinity of an immunoglobulin for an antigen is raised by a 
factor 10 to 100 (Kepler & Bartl, 1998). B cells that express high affinity antibodies on their 
surface will receive a strong survival signal during interactions with other cells, whereas 
those with low affinity antibodies will not, and will die by apoptosis. The process of 
generating antibodies with increased binding affinities is called affinity maturation 
(Neuberger, 2008).  
 
 
1                            65   1        27     1              6
V                              D                 J                 CH
                 V D J          CH
                     V                              J                Ck
1                                   40    1            5
V                             J               C
1                                 40      1       4
  V J          CL
1st response:
V(D)J recombination
and somatic mutations
2nd response: 
somatic hypermutation 
 
Fig. 7. Recombination and hypermutation of immunoglobulins. A yellow rectangle 
represents a point mutation. Recombination and somatic hypermutation are shown for 
heavy chains (left) and for light chains (right). 
This quite complex process for generation of highly specific antibodies is a challenge for the 
obtention of recombinant antibodies. Many factors influence the quality of the recombinant 
antibodies: starting or not from an immunized animals or humans, the size and the quality 
of the libraries, the possibility to mutate the antibodies.  
3.2 Antibody libraries 
3.2.1 Recombinant antibody libraries 
Recombinant antibody libraries have been constructed by cloning antibody heavy- or light-
chain variable genes directly from lymphocytes of animals or human and then expressing as 
a single-chain fragment variable (scFv) single-domain antibodies (VHH) or as an antigen-
binding fragment (Fab) using various display technologies. The recombinant antibody 
technology, an alternative to traditional immunization of animals, facilitates to isolate target 
specific high affinity monoclonal antibodies without immunization by virtue of combination 
with high throughput screening techniques.  
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A strategy for creation of a combinatorial antibody library is very important to isolate high 
specificity and affinity antibodies against target antigens. To date, a variety of different 
antibody libraries have been generated, which range from immune to naive and even 
synthetic antibody libraries (Table 1). Immune libraries derived from IgG genes of 
immunized donors (Sanna et al., 1995) are useful if immunized patients are available but 
have the disadvantage that antibodies can only be made against the antigens used for 
immunization. In contrast, antibodies against virtually any antigen, including self-, non-
immunogenic, or toxic antigens, can be isolated from naive or synthetic libraries. Naive 
libraries from non-immunized donors have been generated by PCR-cloning Ig repertoires 
from various B-cell sources (Marks et al., 1991; Vaughan et al., 1996; Sheets et al., 1998; de 
Haard et al., 1999)) derived from human or camel germ line genes and randomized only in 
the CDR3 regions (Hoogenboom & Winter, 1992; Nissim et al., 1994; de Kruif et al., 1995). 
Synthetic libraries have been generated from a repertoire of 49 human germline VH genes 
segments rearranged in vitro to create a synthetic CDR3 region (Hoogenboom & Winter, 
1992) or derived from a single V-gene with complete randomization of all CDRs (Jirholt et 
al., 1998; Soderlind et al., 2000) (Table 1).  
 
 Synthetic Naive Immune 
V-gene source 
Unrearranged V-
gene segments 
Rearranged-V 
genes from Ig pool 
Rearranged V-genes from 
specific IgG pool 
Contents controlled uncontrolled uncontrolled 
Repertoire 
construction 
Once 
(single pot) 
New repertoire for every 
antigen 
Affinity of 
antibodies 
Depending on library size : 
µM from standard size repertoire (107) 
nM from very large repertoire (1010) 
Biased for high affinity 
(nM if antigen is 
immunogenic) 
specificity Any 
Originally biased 
against self 
Immunodominant 
epitopes, 
biased against self 
Table 1. Comparison between Synthetic, Naive and Immune libraries (according to 
(Hoogenboom, 1997)) 
3.2.2 Immune libraries 
Efficient isolation of specific high affinity binders from relatively small sized libraries was 
shown using immune antibody libraries constructed from B lymphocytes of immunized 
mice, camels or patients with a high antibody titer for particular antigens, in our laboratory 
and by others: a targeted immune library contained typically about 106 clones (Burton, 1991; 
Barbas et al., 1992; Barbas et al., 1992) (Table 1). However, the construction of an immune 
library is not always possible due to the difficulty in obtaining antigen-related B 
lymphocytes.  
The quality of the immune response will likely dictate the outcome of the library selections. 
It is generally accepted that early in the immune response the repertoire of 
immunoglobulins is diverse and of low affinity to the antigen. The process of SHM through 
successive rounds of selection ensures that the surviving B cells develop progressively 
higher affinities, but probably at the expense of diversity. The balance between diversity and 
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affinity is something that may be exploited by researchers depending on the goal of their 
study. 
3.2.3 Non-immune libraries 
The most important parameter in the non-immune antibody library is the library diversity, 
i.e., library size, in an aspect that, in general, the larger the library, the higher the likelihood 
is to isolate high affinity binders to a particular antigen. Typically, a 109 to 1011 library 
diversity has been reported to generate specific high affinity binders with dissociation 
constants in the 1–1000 nM range (Table 1). For example, scFvs against crotoxin, a highly 
toxic--neurotoxin isolated from the venom of the rattlesnake, Crotalus durrissus terrificus, 
have been selected from two non-immune scFv libraries which differ by their size; 
respectively 106 (Nissim et al., 1994) and 1010 diversity (Vaughan et al., 1996). The affinity of 
anti-crotoxin scFvs is in the micromolar range in the first case and in the nanomolar range in 
the second case. Moreover, these latter scFvs possessed an in vivo neutralizing activity 
against a venom toxin.  
However, creating a large antibody library is time consuming and does not always 
guarantee to isolate high affinity binders to any given antigen. Therefore, many attempts 
have been undertaken to make the library size as big as possible, and site-specific 
recombination systems have been created to overcome the library size limitations given by 
the conventional cloning strategies. Besides library generation, the panning process itself 
limits also the library size that can be handled conveniently.   
Therefore, it is important to generate libraries with a high quality of displayed antibodies, 
thus emphasizing the functional library size and not only the apparent library size. For 
instance, one limitation of phage display is that it requires prokaryotic expression of 
antibody fragments. It is well known that there is an unpredictable expression bias against 
some eukaryotic proteins expressed from Escherichia coli because the organism lacks foldases 
and chaperones present in the endoplasmic reticulum of eukaryotic cells that are necessary 
for efficient folding of secreted proteins such as antibody fragments. Even minor sequence 
changes such as single point mutations in the complementarity determining regions (CDRs) 
of Fab fragments can completely eliminate antibody expression in E. coli (Ulrich et al., 1995), 
and a random sampling of a scFv library showed that half of the library had no detectable 
level of scFv in the culture supernatant (Vaughan et al., 1996). Because the protein folding 
and secretory pathways of yeast more closely approximate those of mammalian cells, it has 
been shown that yeast display could provide access to more antibodies than phage display 
(Bowley et al., 2007). In this study, the two approaches were directly compared using the 
same HIV-1 immune scFv cDNA library expressed in phage and yeast display vectors and 
using the same selecting antigen (HIV-1 gp120). After 3 to 4 rounds of selection, sequence 
analysis of individual clones revealed many common antibodies isolated by both 
techniques, but also revealed many novel antibodies derived from the yeast display 
selection that had not previously been described by phage display. It appears that the level 
of expression of correctly folded scFv on the phage surface is one of the most important 
criteria for selection.  
VHH libraries may be an advantageous alternative because VHH are highly soluble, stable, 
easily expressed in E. coli and because they do not tend to aggregate (Muyldermans, 2001; 
Harmsen & de Haard, 2007). Moreover due to their small size (15 kDa compared to 25-30 
kDa for a scFv and 50 kDa for a Fab), VHH could diffuse easily in tissues, bind to poorly 
accessible epitopes for conventional antibody fragments (Desmyter et al., 1996; Stijlemans et 
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al., 2004) and bind non-conventional epitopes (Behar et al., 2009). Chen et al (Chen et al., 
2008) have prepared a phage displayed VH-only domain library by grafting naturally 
occurring CDR2 and CDR3 of heavy chains on a VHH-like scaffold. From this library (size 
2.5 1010) they have selected high quality binders against viral and cancer-related antigens. 
From a non-immune VHH library of 108 diversity, VHH have been selected against various 
viral protein by phage display. These VHH had an affinity in the nanomolar range but more 
interestingly the koff is very low (about 104 to 105 s-1) allowing them to be suitable for 
crystallographic studies (Lafaye –personnal communication).   
3.3 Affinity optimization 
With tools such as phage, yeast and ribosome display available to isolate rapidly specific 
high-potency antibodies from large variant protein populations, a major key to efficient and 
successful in vitro antibody optimization is the introduction of the appropriate sequence 
diversity into the starting antibody. Generally, two approaches can be taken: either amino 
acid residues in the antibody sequence are substituted in a targeted way or mutations are 
generated randomly.  
3.3.1 Affinity increase by targeted mutations 
Antibodies are ideal candidates for targeted sequence diversification because they share a high 
degree of sequence similarity and their conserved immunoglobulin protein fold is well 
studied. Many in vitro affinity maturation efforts using combinatorial libraries in conjunction 
with display technologies have targeted the CDRs harbouring the antigen-binding site. 
Normally, amino acid residues are fully randomized with degenerate oligonucleotides. If 
applied to all positions in a given CDR, however, this approach would create far more variants 
than can be displayed on phage, on yeast or even ribosomes – saturation mutagenesis of a 
CDR of 12 residues, for example, would result in 2012 different variants. In addition, the 
indiscriminate mutation of these residues creates many variants that no longer bind the 
antigen, reducing the functional library size. Scientists have therefore restricted the number of 
mutations by targeting only blocks of around six consecutive residues per library (Thom et al., 
2006) or by mutating four variants in all the CDRs (Laffly et al., 2008) or by mutating only the 
CDRs 1 and 2 (Hoet et al., 2005). Mutagenesis has also been focussed on natural hotspots of 
SHM (Ho et al., 2005). In other works, the residues to be targeted were chosen based on 
mutational or structural analyses as well as on molecular models (Yelton et al., 1995; Osbourn 
et al., 1996; Chen & Stollar, 1999). Further affinity improvements have been achieved by 
recombining mutations within the same or different CDRs of improved variants (Jackson et al., 
1995; Yelton et al., 1995; Chen & Stollar, 1999; Rajpal et al., 2005). Despite some substantial 
gains, such an approach is unpredictable. As an alternative, CDRs were sequentially mutated 
by iterative constructions and pannings of libraries, starting with CDR3, in a strategy named  
« CDR walking » (Yang et al., 1995; Schier et al., 1996). Although this results in greater 
improvements, it is time consuming and permits only one set of amino acid changes to 
recombine with new mutations.  
3.3.2 Affinity increase by random mutations 
In addition to the targeted strategies, several random mutagenesis methods can be used to 
improve antibody potency. One is the shuffling of gene segments, where VH and VL 
populations, for example, can be randomly recombined with each other (Figini et al., 1994; 
www.intechopen.com
 Systems and Computational Biology – Bioinformatics and Computational Modeling 
 
14
Schier et al., 1996) or be performed with CDRs (Jirholt et al., 1998; Knappik et al., 2000). An 
alternative approach is the possibility that independent repertoires of heavy chain (HC) and 
light chain (LC) can be constructed in haploid yeast strains of opposite mating type. These 
separate repertoires can then be combined by highly efficient yeast mating. Using this 
approach, Blaise et al (Blaise et al., 2004) have rapidly generated a human Fab yeast display 
library of over 109 clones, allowing the selection of high affinity Fab by YSD using a 
repeating process of mating- driven chain shuffling and flow cytometric sorting.  
Another approach is the indiscriminate mutation of nucleotides using the low-fidelity Taq 
DNA polymerase (Hanes et al., 2000), error-prone PCR (Hawkins et al., 1992; Daugherty et 
al., 2000; Jermutus et al., 2001; van den Beucken et al., 2003), the error-prone Qbeta RNA 
replicase (Irving et al., 2001) or E. coli mutator strains (Irving et al., 1996; Low et al., 1996; 
Coia et al., 2001) before and in-between rounds of selection. Shuffling and random point 
mutagenesis are particularly useful when used in conjunction with targeted approaches 
because they enable the simultaneous evolution of non-targeted regions (Thom et al., 2006); 
in addition, they are powerful when performed together because individual point mutations 
can recombine and cooperate, again leading to synergistic potency improvements. This has 
created some of the highest affinity antibodies produced so far, with dissociation constants 
in the low picomolar range (Zahnd et al., 2004) and in a study using yeast display, even in 
the femtomolar range (Boder et al., 2000). When performed separately, random mutagenesis 
can help identify mutation hotspots, defined as amino acid residues mutated frequently in a 
population. To this end, a variant library generated by error-prone PCR, for example, might 
be subjected to affinity selections followed by the sequencing of improved scFvs. In a 
manner similar to somatic hypermutation, this method leads to the accumulation of 
mutations responsible for potency gains mainly in CDRs, despite having been introduced 
randomly throughout the whole scFv coding sequence (Thom et al., 2006). 
3.3.3 Affinity increase by selection optimization 
Mutant libraries are often screened under conditions where the binding interaction has 
reached equilibrium with a limiting concentration of soluble antigen to select mutants 
having higher affinity. When labelled with biotin, for example, the antigen and the bound 
scFv–phage, scFv-yeast or scFv–ribosome–mRNA complexes can be pulled down with 
streptavidin-coated magnetic beads. The antigen concentration chosen should be below the 
KD of the antibody at the first round of selection and then reduced incrementally during 
subsequent cycles to enrich for variants with lower KD (Hawkins et al., 1992; Schier et al., 
1996). Selections have been performed in the presence of an excess of competitor antigen or 
antibody, resulting specifically in variants with lower off-rates (Hawkins et al., 1992; 
Jermutus et al., 2001; Zahnd et al., 2004; Laffly et al., 2008).  
Protein affinity maturation has been one of the most successful applications of YSD. Initial 
studies led by Wittrup et al. used an anti-fluorescein scFv to show the effectiveness of YSD 
in protein affinity maturation (Boder et al., 2000; Feldhaus & Siegel, 2004). Since each yeast 
cell is capable of displaying 104 to 105 copies of a single scFv (Boder & Wittrup, 1997), 
fluorescence from each cell can be readily detected and accurately quantified by flow 
cytometry. This feature of YSD allows not only precise and highly reproducible affinity 
measurement, but also rapid enrichment of high-affinity populations within mutant 
libraries (Boder et al., 2000). Moreover, on-rate selections have been realized only with yeast 
display, which profits from using flow cytometric cell sorting to finely discriminate variants 
with specified binding kinetics (Razai et al., 2005).  
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The selected antibodies can be tested for increased affinity but should preferentially be 
screened for improved potency in a relevant cell-based assay because the sequence 
diversification and selection process might also have enriched variants with increased 
folding efficiency and thermodynamic stability, both contributing to potency and, 
ultimately, efficacy. 
3.4 Conclusions on the parallel processing of binders 
Phage, yeast and ribosome display were proven to be powerful methods for screening 
libraries of antibodies. By means of selection from large antibody repertoires, a wide variety 
of antibodies have been generated in the form of scFv, VHH or Fab fragments. After a few 
rounds of panning or selection on soluble antigens and subsequent amplification in E. coli, 
large numbers of selected clones have to be analyzed with respect to antigen specificity, and 
binding affinity. Analysis of these selected binders is usually performed by ELISA. 
Hopefully, the introduction of automated screening methods to the display process 
provides the opportunity to evaluate hundreds of antibodies in downstream assays. 
Secondary assays should minimally provide a relative affinity ranking and, if possible, 
reliable estimates of kinetic or equilibrium affinity constants for each of the hits identified in 
the primary screen.  
Surface plasmon resonance (SPR) methods has been used to measure the thermodynamic 
and kinetic parameters of antigen-antibody interactions. An SPR secondary screening assay 
must be capable of rapidly analyzing all the unique antibodies discovered in the primary 
screen. The first generations of widely used commercial systems from Biacore process only 
one sample at a time and this limits the throughput for antibody fragments screening to 
approximately 100 samples per day. Recently however, several biosensors were introduced 
to increase the number of samples processed with different approaches for sample delivery 
(Wassaf et al., 2006) (Safsten et al., 2006; Nahshol et al., 2008). 
To reduce the number of antibodies tested and so far the amount of antigen used, it is 
crucial to analyze the diversity of the antibody fragments after the first screening performed 
by ELISA. Usually after few rounds of selection, a limited number of clones, found in 
several copies, are obtained. In that case, it is un-necessary to analyze such redundant 
clones. It is the reason why we have decided in our laboratory to sequence the clones after 
the first screening, then to analyze only the unique clones by SPR in a secondary screening. 
Despite the growing knowledge around antibody structures and protein–protein 
interactions, and the rapid development of in silico evolution, molecular modelling and 
protein–protein docking tools, it is still nearly impossible to predict the multitude of 
mutations resulting in improved antibody potency. Moreover, specific structural 
information – on the antibody to be optimized (paratope), its antigen (epitope) and their 
interaction – can lack the high resolution required to determine accurately important details 
such as side-chain conformations, hydrogen-bonding patterns and the position of water 
molecules. Therefore, the most effective way to improve antibody potencies remains the use 
of display technologies to interrogate large variant populations, using either targeted or 
random mutagenesis strategies. 
4. Catalysts analyzed by parallel processing 
4.1 Enzyme libraries 
To isolate rare catalysts of interest for specific chemical reactions, the parallel processing of 
millions of mutant enzymes turned out to be a successful strategy (Figures 3&8). Various 
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types of protein libraries can be constructed. Almost random protein sequences have been 
designed and submitted to selection for the isolation of nucleic acid ligases (Seelig & 
Szostak, 2007).  Given that most enzymes have more than 50 amino acids, and that each 
amino acid can be one out of twenty in the standard genetic code, 2050 distinct sequences can 
be considered. The parallel or serial processing of so many proteins cannot be conceived 
experimentally. A useful strategy then relies on the directed evolution of known enzymes, 
which catalyze chemical reactions that are similar to the reactions of interest (Figure 8). 
Enzyme libraries have been constructed by random mutagenesis of the corresponding 
genes. This can be achieved by introduction of manganese ions within PCR mixtures during 
amplification of the gene encoding the enzyme. Manganese ions alter the fidelity of the 
DNA-dependent DNA polymerase used for amplification and provided their concentration 
is precisely adjusted, the average number of base substitutions per gene can be accurately 
evaluated (Cadwell & Joyce, 1994). Concentrations of deoxynucleotides triphosphates can be 
further adapted so as to define the relative rates of different base substitutions (Fromant et 
al., 1995). 
 
 
known reaction
catalysed by E 
available
substrate
product
of interest
directed
evolution
A B
S PEÕ
 
Fig. 8. Strategy for the isolation of a catalyst of interest E’ for the reaction from S to P by 
directed evolution of an enzyme E catalyzing a similar chemical reaction converting  
A into B. 
Other enzyme libraries have been constructed by directed mutagenesis at specific sites 
within proteins, for example in our laboratory. Known x-ray crystal structures of enzymes in 
complex with their substrates can be used as a basis to identify the specific amino acids 
known to bind the substrates at the active site (Figure 9).   
Oligonucleotides can be further synthesized with random mutations introduced specifically 
at the very few codons coding amino acids known to interact with the substrates. PCR 
assembly of such oligonucleotides can then be used to reconstitute full-length open reading 
frames coding for mutant proteins. Experience from our laboratory indicates that protein 
libraries designed by introduction of quasi-random mutations over an entire protein domain 
yield a higher number of catalysts of interest than protein libraries carefully designed by 
introduction of mutations at specific sites within the active site. This strategy requires 
nevertheless an efficient parallel processing strategy for analysis of millions of protein 
mutants. 
’
www.intechopen.com
Parallel Processing of Complex  
Biomolecular Information: Combining Experimental and Computational Approaches 
 
17 
 
 
Fig. 9. Comparison of Thermus aquaticus DNA polymerase I’s Stoffel fragment structures 
with (2ktq) and without a DNA duplex (1jxe) at the active site. 
4.2 Selections from enzyme libraries 
Design of selections for the isolation of catalysts from large protein repertoires has been far 
from obvious. The various parallel processing strategies to identify active enzymes rely 
generally on selections for binding. Selections for binding to suicide inhibitors were first 
tested (Soumillion et al., 1994). Selection of protein mutants for binding to transition state 
analogues yield in principle catalysts. This approach remains delicate, possibly because of 
the rough similarity between transition states and transition state analogues whose stability 
is required for the selections, and because of the time required to synthesize transition state 
analogues by organic synthesis. Successful parallel processing strategies for the isolation of 
catalysts relied on the selection of multiple products bound to the enzyme complex that 
catalyzed the chemical reaction. These in vitro selections are furthermore selections for the 
highest catalytic turnovers (Figure 10). Populations of enzymes with the highest catalytic 
efficiencies are thereby isolated.  
Sequencing of the genes encoding hundred variants of the selected population then allows 
multiple sequence alignments to be carried out for the identification of recurrent mutations 
which characterize the catalytic activity change or improvement. Further characterization of 
isolated catalysts consists of the measurement of the kinetic parameters for the chemical 
reactions studied. Improvements of the catalytic efficiencies by several orders of magnitude 
have been described in the literature for several enzymes. These results have important 
applications in the field of biocatalysis. 
Alternatively, for substrate-cleaving reaction, the concept of catalytic elution was reported 
(Pedersen et al., 1998): complexes between enzymes displayed on the surface of 
bacteriophages and their substrates bound to a solid phase are formed. Activation of the 
enzyme results in release of the phage-enzyme from the solid phase if the enzyme is 
active, while inactive enzymes remain bound to the solid phase (Soumillion & Fastrez, 
2001). 
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Fig. 10. Comparison of a highly active enzyme (white) efficiently captured by affinity 
chromatography for the product with a protein catalyzing a single substrate to product 
conversion (blue) unlikely to be isolated by affinity chromatography for the product. 
4.3 Conclusion for enzymes 
The parallel processing of molecular information on the catalytic activity of proteins (« Is the 
protein a catalyst or not ? ») is remarkably achieved by in vitro selection from large libraries 
of millions or billions of mutant proteins. Reduction of the large diversity into a small 
diversity of hundred(s) of variant proteins with the catalytic activity of interest allows 
characterization by serial processing to be accomplished. The sequencing of the 
corresponding genes for hundred(s) of variants allows computation of alignments for 
multiple sequences. The yield of protein production and the catalytic efficiencies for tens of 
selected variants allow the most promising variant protein to be identified. These results 
define sequence-activity relationships for enzymes. If enzyme-substrate complex structures 
are available, the sequence-structure-activity relationships that can be derived provide the 
central information for use in further biocatalytic applications. 
5. Conclusion 
Molecular biology, bioinformatics and protein engineering reached in the last decades a 
state allowing the isolation of proteins for desired functions of interest. Proteins can be 
isolated with a binding specificity for a given target, while enzymes can be isolated for given 
chemical reactions. Binding proteins and antibodies in particular found remarkable 
applications in the field of therapeutics. Enzymes turn out to be extremely useful in the field 
of biocatalysis for the production of chemicals at industrial scales within a sustainable 
environment. 
Over the last twenty years, the use of antibodies has increased greatly, both as tools for basic 
research and diagnostics, and as therapeutic agents. This has largely been driven by ongoing 
advances in recombinant antibody technology. Today, more than 20 recombinant antibodies 
are widely used in clinic such as the human anti-TNF antibody marketed as Humira® and 
many more antibodies are currently in clinical trials. 
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Satisfying industrial needs in the field of biocatalysis requires efficient enzymes to be 
isolated. While natural enzymes rarely fulfill industrial needs, and as long as computational 
approaches alone do not allow the sequences of protein catalysts to be designed, 
experimental methods such as the parallel processing strategies relying on in vitro selection 
combined with computational approaches for the characterization of catalysts may well be 
the most powerful strategies for the isolation of enzymes for given chemical reactions. Most 
notably, these new biocatalysts act in aqueous solutions without organic solvents at large 
scale and are ideally suited for green industrial processes. 
A highly efficient design of binders and catalysts according to function can make use of a 
unique strategy: selection from large repertoires of proteins according to a function yield 
secondary protein repertoires of high interest, which can then be processed in series for their 
characterization due to their reduced diversity. Characterization involves sequencing of the 
corresponding genes for alignment of numerous protein sequences so as to define consensus 
sequences. This is the major advantage of molecular information parallel processing 
(MIPP) strategies: defining conserved amino acids within protein scaffolds tightly linked to 
function.  
In conclusion, the parallel processing of biomolecular information (« Does the protein bind 
the target ? » or « Is the protein a catalyst for the chemical reaction ? ») is so far best achieved 
experimentally by using repertoires of millions or billions of proteins. Analysis of 
hundred(s) of protein variants is then best done computationally: use of multiple sequence 
alignment algorithms yields then sequence-activity relationships required for protein 
applications. Further biochemical and biophysical characterization of proteins (« Does the 
protein tend to form dimers or to aggregate ? », « Can the protein be produced at high 
level ? » , « What is the protein’s pI ? ») is essential for their final use which may require high 
level soluble expression or cell penetration properties. In this respect, the development of 
algorithms analyzing protein properties remains a major challenge. 
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